Anavex Life Sciences Corp (AVXL) Stock Forecast & Price Target
Anavex Life Sciences Corp · NASDAQ
$2.58+0.09 (+3.40%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Anavex Life Sciences Corp, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $20.00 to $24.00, so the covering firms are broadly aligned. The average target of $22.00 sits 751% above the current $2.58. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and -91% next, consensus EPS building from about $-0.08 next quarter toward $-0.55 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Anavex Life Sciences Corp.
As of Jul, 2 of 3 firms rate AVXL a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AVXL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.08
Range $-0.08 – $-0.08 · 2 analysts · -50% YoY
Next period, 2 analysts expect Anavex Life Sciences Corp to earn $-0.08 a share (range $-0.08 – $-0.08), versus $-0.16 a year earlier. Full-year consensus is $-0.33, growing to $-0.55 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
Top analysts covering Anavex Life Sciences Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AVXL.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$20.00+673.7% to target
Overall win rate
37%
+ Follow
#2
Jason Kolbert
D. Boral Capital · Rank #346
Buy
$24.00+828.4% to target
Overall win rate
22%
+ Follow
#3
RS
Ram Selvaraju
H.C. Wainwright
Buy
$20.00+673.7% to target
Coverage
—
+ Follow
#4
SR
Soumit Roy
Jones Trading
Hold
No targeton AVXL
Coverage
—
+ Follow
AVXL stock forecast FAQ
What is AVXL's average 12-month price target?+
The 2 analysts with a live target average $22.00 for Anavex Life Sciences Corp over the next 12 months, ranging from a $24.00 high to a $20.00 low.
Is AVXL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AVXL?+
The Street-high target is $24.00 (D. Boral Capital), and the Street-low is $20.00 (HC Wainwright & Co.). The average of all 2 active targets is $22.00.
How many Wall Street analysts cover AVXL?+
3 analysts have an active rating on Anavex Life Sciences Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering AVXL?+
Among analysts who currently cover AVXL, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #249). Their current call is Buy with a $20.00 target.
What is Anavex Life Sciences Corp's projected EPS for next quarter?+
The consensus estimate is $-0.08 per share (range $-0.08 – $-0.08) across 2 analysts. Full-year EPS is projected at $-0.33, rising to $-0.55 the following year.
How much revenue is Anavex Life Sciences Corp expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading AVXL lately?+
As of Jul, 2 of 3 firms rate AVXL a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AVXL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
